0001062993-23-022436.txt : 20231212 0001062993-23-022436.hdr.sgml : 20231212 20231212163118 ACCESSION NUMBER: 0001062993-23-022436 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231208 FILED AS OF DATE: 20231212 DATE AS OF CHANGE: 20231212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Van Strydonck, Gerald E. CENTRAL INDEX KEY: 0001748247 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38624 FILM NUMBER: 231481622 MAIL ADDRESS: STREET 1: 1895 MOUNT HOPE AVENUE CITY: ROCHESTER STATE: NY ZIP: 14620 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VACCINEX, INC. CENTRAL INDEX KEY: 0001205922 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 161603202 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1895 MOUNT HOPE AVE CITY: ROCHESTER STATE: NY ZIP: 14620 BUSINESS PHONE: 585-271-2700 MAIL ADDRESS: STREET 1: 1895 MOUNT HOPE AVE CITY: ROCHESTER STATE: NY ZIP: 14620 FORMER COMPANY: FORMER CONFORMED NAME: VACCINEX INC DATE OF NAME CHANGE: 20021114 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2023-12-08 0001205922 VACCINEX, INC. VCNX 0001748247 Van Strydonck, Gerald E. C/O VACCINEX, INC. 1895 MOUNT HOPE AVENUE ROCHESTER NY 14620 1 0 0 0 0 Common Stock 2023-12-08 4 S 0 1334 0.67 D 3149 D Stock Option (Right to Buy) 204.0 2027-09-15 Common Stock 426 426 D Stock Option (Right to Buy) 78.9 2029-03-30 Common Stock 166 166 D Stock Option (Right to Buy) 116.7 2020-05-15 Common Stock 514 514 D Stock Option (Right to Buy) 82.8 2029-06-29 Common Stock 159 159 D Stock Option (Right to Buy) 107.55 2029-09-27 Common Stock 123 123 D Stock Option (Right to Buy) 72.75 2029-12-28 Common Stock 182 182 D Stock Option (Right to Buy) 59.25 2021-05-14 Common Stock 1045 1045 D Stock Option (Right to Buy) 32.25 2022-05-11 Common Stock 1905 1905 D Stock Option (Right to Buy) 16.8 2023-05-12 Common Stock 3550 3550 D Stock Option (Right to Buy) 6.15 2024-05-11 Common Stock 9589 9589 D Exercisable in full as of the date of this report. This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first. This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first. This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first. This option expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first. This option expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first. On September 25, 2023, Vaccinex, Inc. effected a 1-for-15 reverse stock split (the "Reverse Stock Split"). All figures in this Form 4 reflect the Reverse Stock Split. /s/ Scott E. Royer, Attorney-in-Fact for Gerald Van Strydonck 2023-12-12